Autoimmune Life Blog

A day prior to her 51st birthday last year, Aline Keller fell in the shower. “Within one week I had so much pain and swelling in my hands and joints that I could barely walk,” she says.

We all know you can give blood to help ill or injured people who need it, but did you know you can also donate blood for research?

For most people, the onset of type 1 diabetes (T1D) seems to occur suddenly, often resulting in a trip to the emergency room with life-threatening complications.

Benaroya Research Institute (BRI) and Seattle Children’s Research Institute (SCRI) are pioneering the use of gene editing techniques in efforts to control type 1 diabetes (T1D).

In March of 2015, 13-year-old Lizzie Blockhus experienced a week of being very tired and not feeling well. “I woke up in the middle of night and was dying of thirst,” she explains. “Then I was at my sister’s soccer game, dying of thirst again and I knew something wasn’t right.

This research update is on a variety of studies that BRI is conducting or collaborating on with other institutions. They are tackling various scientific and immunologic questions that explore innovative ways to fight MS from the lab to clinical studies.

Forty-year-old Cheryl Hile runs marathons, bicycles and holds a demanding full-time job—impressive accomplishments but, on the surface, not especially remarkable in this day and age.

Benaroya Research Institute (BRI) has been awarded another leadership role in type 1 diabetes research. Carla Greenbaum, MD, BRI’s director of the Diabetes Research Program and Clinical Research Center, has been named chair of Type 1 Diabetes TrialNet.

For nearly 45 years, Marcia Wollam has cared for people at Virginia Mason Hospital. Initially she served as an LPN and then she became a patient flow coordinator on the Rehabilitation Unit. But she always wanted to do more to help people.

In clinical trials, not all individuals respond in the same way to particular immunological therapies.